advertisement
Zhu L 25
Showing records 1 to 25 | Display all abstracts from Zhu L121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Wu SN
Therapeutic advances in drug safety 2024; 15: 20420986241285929
121134 The applications of anterior segment optical coherence tomography in glaucoma: a 20-year bibliometric analysis
Huang Y
PeerJ 2024; 12: e18611
121342 Anti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management
Huang Y
Colloids and surfaces. B, Biointerfaces 2025; 245: 114261
120213 Role and mechanism of autonomic nervous system regulation in primary glaucoma
Zhu L
Chinese Journal of Ophthalmology 2024; 60: 780-786
121342 Anti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management
Ding X
Colloids and surfaces. B, Biointerfaces 2025; 245: 114261
121134 The applications of anterior segment optical coherence tomography in glaucoma: a 20-year bibliometric analysis
Gong D
PeerJ 2024; 12: e18611
120213 Role and mechanism of autonomic nervous system regulation in primary glaucoma
Shen XL
Chinese Journal of Ophthalmology 2024; 60: 780-786
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Huang C; Wang YQ
Therapeutic advances in drug safety 2024; 15: 20420986241285929
121342 Anti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management
Zhu L
Colloids and surfaces. B, Biointerfaces 2025; 245: 114261
121134 The applications of anterior segment optical coherence tomography in glaucoma: a 20-year bibliometric analysis
Dang K
PeerJ 2024; 12: e18611
120213 Role and mechanism of autonomic nervous system regulation in primary glaucoma
Li AZ; Wang JT
Chinese Journal of Ophthalmology 2024; 60: 780-786
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Li X
Therapeutic advances in drug safety 2024; 15: 20420986241285929
121342 Anti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management
Zhang X
Colloids and surfaces. B, Biointerfaces 2025; 245: 114261
121134 The applications of anterior segment optical coherence tomography in glaucoma: a 20-year bibliometric analysis
Zhu L
PeerJ 2024; 12: e18611
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Zhang SQ
Therapeutic advances in drug safety 2024; 15: 20420986241285929
121342 Anti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management
Wang X
Colloids and surfaces. B, Biointerfaces 2025; 245: 114261
121134 The applications of anterior segment optical coherence tomography in glaucoma: a 20-year bibliometric analysis
Guo J; Yang W
PeerJ 2024; 12: e18611
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Chen XD
Therapeutic advances in drug safety 2024; 15: 20420986241285929
121342 Anti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management
Ma F
Colloids and surfaces. B, Biointerfaces 2025; 245: 114261
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Chen XD
Therapeutic advances in drug safety 2024; 15: 20420986241285929
121134 The applications of anterior segment optical coherence tomography in glaucoma: a 20-year bibliometric analysis
Wang J
PeerJ 2024; 12: e18611
121342 Anti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management
Chen Y
Colloids and surfaces. B, Biointerfaces 2025; 245: 114261
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Qin DY
Therapeutic advances in drug safety 2024; 15: 20420986241285929
121342 Anti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management
Nan K
Colloids and surfaces. B, Biointerfaces 2025; 245: 114261
121073 Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Zhu L; Wen JY; Luo NC; Hu J; Liu Z
Therapeutic advances in drug safety 2024; 15: 20420986241285929
